Number of participating innovations and countries per year 2007-2023

Country

Prize

Organization

Innovation

Description

Country

Finland

Prize

Large companies

Organization

Outotec Oy

Innovation

An innovative new method of extracting copper from ore.

Description

Establish a decision system through big data analysis to enable the visual display of real time quality data of all production processes, intelligent detection and prediction of any quality abnormity, and automatically manage quality activities in digital way.

Country

Finland

Prize

Public sector and nonprofit organizations

Organization

City of Lahti

Innovation

Oral health care

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.

Country

Finland

Prize

Small and medium sized enterprises

Organization

Smartum Oy

Innovation

Sports vouchers

Description

Alpha DaRT is a novel radiation technology that can treat recurrent, metastatic, and locally advanced cancers. What makes this new therapy unique among radiation therapies is that, for the first time, it employs alpha particles for treatment of solid tumors. Alpha DaRT treatment consists of intratumorally-inserted radionuclides that emit alpha particles which kill tumor cells, sparing healthy cells nearby. In comparison to existing radiation therapies, it is highly effective, safe, and tolerable for patients. Alpha DaRT can potentially fill a huge unmet need for treatment of advanced cancers that are resistant or have become refractory to prior conventional therapies such as X-rays and chemotherapy, and when surgery is not an option.